Purpose To assess the hemodynamic and structural differences between glaucoma patients who developed retinal vein occlusion (RVO) and those who did not.

Study Design Retrospective, single-center, cross-sectional study

Methods This study included glaucoma patients who underwent a heart rate variability (HRV) test between January 2018 and July 2024. Patients were subdivided into RVO and non-RVO groups. Baseline mean deviation (MD) and pattern deviation (PSD) of the visual field and optical coherence tomography parameters were analyzed.

Results Twenty-nine glaucoma patients with RVO and 34 glaucoma patients without RVO were included. Baseline MD and PSD had no difference (MD: −5.98 ± 9.05 vs. −3.70 ± 4.70, p=0.114; PSD: 3.88 ± 3.78 vs. 3.98 ± 3.96, p=0.883). HRV parameters, specifically Standard Deviation of NN interval (SDNN) and root-mean-square of successive differences (rMSSD), were significantly lower in the RVO group (SDNN: 22.12 ± 8.27 vs. 36.71 ± 24.74, p=0.002; rMSSD: 16.34±9.55 vs. 29.87±31.58, p=0.022). Statistically significant choroidal vascularity index difference was also observed between groups (64.62±7.38 vs. 67.49±5.90, p=0.045). Multivariate logistic regression analysis identified hypertension medication use (p=0.019) and SDNN (p=0.003) as factors associated with RVO development in glaucoma patients.

Conclusion This is the first reported study to analyze the association between hemodynamic instability and RVO development in glaucoma patients. Our results showed that RVO patients had lower HRV parameters, with SDNN being significantly associated with RVO development. We believe that HRV can be an indicator for identifying glaucoma patients at risk for RVO, though further studies are needed to validate this association.

The authors have declared no competing interest.

N/A

The author(s) received no specific funding for this work.

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Institutional Review Board (IRB) of Seoul St. Mary’s Hospital, Catholic University of Korea (KC24RASI0497), and adhered to the tenets of the Declaration of Helsinki. As the study was conducted retrospectively, the local IRB of the Catholic University of Korea waived the need for informed consent.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

All relevant data are within the manuscript and its Supporting Information files.